Wall Street Analysts Think Veracyte (VCYT) Could Surge 39.16%: Read This Before Placing a BetZacks Investment Research • 05/05/26
Veracyte Announces New Data at AUA 2026 Highlighting the Power of the Decipher Portfolio to Advance Personalized Care in Urologic CancersBusiness Wire • 04/28/26
Veracyte (VCYT) Recently Broke Out Above the 50-Day Moving AverageZacks Investment Research • 04/27/26
Veracyte (VCYT) Down 15.4% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/27/26
Veracyte Q4 Earnings Beat Estimates, Revenues Grow Y/Y, Stock RisesZacks Investment Research • 02/26/26
Veracyte (VCYT) Loses 20.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 02/05/26
Veracyte to Release Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026Business Wire • 02/04/26
Veracyte, Inc. (VCYT) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/15/26